Adrien Herlédan

Title: Adrien Herlédan and a Protein Microarray for Characterizing Monoclonal Immunoglobulins.

Introduction

Adrien Herlédan is an inventor associated with Lille, France. His patent work addresses the characterization of monoclonal immunoglobulins in patients with Monoclonal Gammopathy of Undetermined Significance (MGUS) or myeloma.

Latest Patents

The provided information identifies one patent associated with Herlédan: “Protein microarray for characterizing the specificity of the monoclonal immunoglobulins of MGUS or myeloma patients.” The invention describes a protein microarray comprising a substrate and immobilized antigens selected from infectious-agent antigens, self-antigens, or both. The microarray is intended to characterize the specificity of patients’ monoclonal immunoglobulins. Potential applications include supporting diagnosis and prognosis, helping prevent MGUS from progressing to myeloma, informing treatment choices, and monitoring responses to therapy. Herlédan is credited with 1 patent in the supplied data.

Career Highlights

The supplied information associates Herlédan with Hermouet, Sylvie. It does not provide further details about his roles or career history.

Collaborations

Edith Bigot-Corbel and Cathy Charlier are listed as Herlédan’s coworkers. The available information does not specify their roles in the patent or the invention.

Conclusion

Adrien Herlédan’s identified patent presents a protein-microarray approach for characterizing monoclonal immunoglobulins, with potential applications in the diagnosis, prognosis, and treatment monitoring of MGUS and myeloma.